https://qz.com/eli-lilly-dave-ricks-orforglipron-tariffs-us-1851776807
Eli Lilly (LLY) CEO Dave Ricks said Friday that the company will make its planned GLP-1 weight-loss pill in the U.S. amid President Donald Trump’s sweeping tariffs and his push to get companies to move production inside the country’s borders.Read more…
Eli Lilly promises to make new weight loss pill in the U.S.
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- Gold ends week higher despite Powell’s pushback, trade uncertainty lingers
- EUR/USD climbs as US Dollar weakens on trade tensions
- Forex Today: Markets stabilize as trading volume thins out on Easter Friday
- US Dollar Index hovers near 99.50 as trading activity remains muted due to Good Friday
- Follow the leaders
- Starbucks gets a new dress code, Tesla falls behind, and Trump wants Powell out: Business news roundup
- Tumbling stocks, recession fears, and a retail sales surge: Markets news roundup
- Meta’s antitrust trial, Nvidia’s stateside manufacturing, and 7 AI breakthroughs: Tech news roundup
- Meta’s antitrust trial heats up: Here’s what we’ve learned so far
- India Bank Loan Growth remains unchanged at 11% in March 31
More from UncategorizedMore posts in Uncategorized »
- Gold ends week higher despite Powell’s pushback, trade uncertainty lingers
- EUR/USD climbs as US Dollar weakens on trade tensions
- Forex Today: Markets stabilize as trading volume thins out on Easter Friday
- US Dollar Index hovers near 99.50 as trading activity remains muted due to Good Friday
- Follow the leaders
- Starbucks gets a new dress code, Tesla falls behind, and Trump wants Powell out: Business news roundup
- Tumbling stocks, recession fears, and a retail sales surge: Markets news roundup
- Meta’s antitrust trial, Nvidia’s stateside manufacturing, and 7 AI breakthroughs: Tech news roundup
- Meta’s antitrust trial heats up: Here’s what we’ve learned so far
- India Bank Loan Growth remains unchanged at 11% in March 31